Danimer Scientific, Inc.
DNMR
$1.13
-$0.165-12.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.63M | 7.63M | 10.22M | 10.95M | 10.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.63M | 7.63M | 10.22M | 10.95M | 10.95M |
| Cost of Revenue | 15.19M | 13.78M | 15.78M | 16.60M | 18.01M |
| Gross Profit | -6.56M | -6.15M | -5.56M | -5.66M | -7.06M |
| SG&A Expenses | 7.86M | 7.75M | 7.87M | 17.85M | 17.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.39M | 26.39M | 28.75M | 41.78M | 42.12M |
| Operating Income | -18.76M | -18.76M | -18.52M | -30.83M | -31.18M |
| Income Before Tax | -21.84M | -22.66M | -27.26M | -39.43M | -39.69M |
| Income Tax Expenses | 2.00K | 2.00K | 2.00K | 2.00K | 468.00K |
| Earnings from Continuing Operations | -21.84M | -22.66M | -27.26M | -39.43M | -40.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.84M | -22.66M | -27.26M | -39.43M | -40.16M |
| EBIT | -18.76M | -18.76M | -18.52M | -30.83M | -31.18M |
| EBITDA | -11.38M | -11.33M | -10.99M | -23.46M | -23.92M |
| EPS Basic | -7.30 | -7.78 | -10.49 | -15.44 | -15.74 |
| Normalized Basic EPS | -5.97 | -4.74 | -6.56 | -9.60 | -9.71 |
| EPS Diluted | -7.30 | -7.78 | -10.49 | -15.44 | -15.74 |
| Normalized Diluted EPS | -5.97 | -4.74 | -6.56 | -9.60 | -9.71 |
| Average Basic Shares Outstanding | 2.99M | 2.91M | 2.60M | 2.55M | 2.55M |
| Average Diluted Shares Outstanding | 2.99M | 2.91M | 2.60M | 2.55M | 2.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
